Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.3K
Genetic Screens02:46

Genetic Screens

5.1K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Pfcrt</i> copy number amplification detected in a <i>Plasmodium falciparum</i> outbreak.

bioRxiv : the preprint server for biology·2026
Same author

Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis.

Diabetes, obesity & metabolism·2026
Same author

Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation.

The Journal of rheumatology·2026
Same author

Discovery of a Highly Potent and Selective Small-Molecule Inhibitor of <i>In Vivo</i> Anaerobic Choline Metabolism by Human Gut Bacteria.

Journal of medicinal chemistry·2026
Same author

Discovery and Characterization of Diverse Non-nucleotide Inhibitors of DNPH1 Using an Integrated Hit Finding Strategy.

ACS medicinal chemistry letters·2026
Same author

Population Pharmacokinetics and Optimal Exposure of Antithymocyte Globulin in Myeloablative Hematopoietic Cell Transplantation.

Transplantation and cellular therapy·2026
Same journal

Potential role of the <i>Trpv4 c.1491+1G>A</i> mutation in pulmonary fibrosis in a gene-edited mouse model.

Frontiers in genetics·2026
Same journal

Utilization of whole exome sequencing to identify hereditary mutations in Palestinian families with hereditary cancers.

Frontiers in genetics·2026
Same journal

Research of N-acetyl-L-cysteine on CD40-CD40L pathway in pulmonary fibrosis induced by silicon dioxide.

Frontiers in genetics·2026
Same journal

Novel variants in LSS related hypotrichosis simplex 14.

Frontiers in genetics·2026
Same journal

Network-based analysis identifies shared mechanisms between ischemic stroke and myocardial infarction and therapeutic ingredients of Buyang Huanwu Decoction.

Frontiers in genetics·2026
Same journal

GWAS analysis of a depression cohort defined by an EHR-phenotyping algorithm reveals the role of immune regulations in depression risk.

Frontiers in genetics·2026
See all related articles

Related Experiment Video

Updated: Sep 7, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using

Chiyun Lee1, Junxia Lin2, Andrzej Prokop3

  • 1Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.

Frontiers in Genetics
|June 17, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces StarGazer, a hybrid intelligence pipeline for drug discovery. It integrates multi-omics data with a novel scoring system to prioritize drug targets and identify new drug-indication associations.

Keywords:
data integrationdrug discoveryhybrid intelligencemulti-omicsrepositioningstargazerstreamlittarget prioritization

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K

Related Experiment Videos

Last Updated: Sep 7, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • Drug discovery and repositioning rely heavily on effective target prioritization.
  • Existing multi-omics data integration methods are limited in scope.
  • Hybrid intelligence approaches can enhance drug target discovery by combining human expertise with computational power.

Purpose of the Study:

  • To develop a hybrid intelligence framework for integrating multi-omics data for drug target prioritization.
  • To create a novel numerical scoring system for bridging different omics layers.
  • To identify novel drug-indication associations and facilitate rapid drug target discovery.

Main Methods:

  • Developed the StarGazer pipeline, a hybrid intelligence solution.
  • Integrated multi-source, multi-omics data (genomics, phenomics, proteomics).
  • Implemented a novel target prioritization scoring system within an interactive Python-based Streamlit dashboard.

Main Results:

  • The StarGazer pipeline provides target prioritization scores for genes linked to 1844 phenotypic traits.
  • Demonstrated a method for integrating diverse biological datasets.
  • Facilitated rapid assessment of potential drug targets.

Conclusions:

  • The StarGazer pipeline offers a powerful tool for drug discovery and repositioning.
  • Integrating multi-omics data via a unified scoring system enhances target identification.
  • Hybrid intelligence frameworks are promising for advancing pharmaceutical research.